Microarrays Inc

Microarrays Inc (MI) is a biotechnology startup founded in 1999 and specializing in array products for biological research, detection, and diagnostics. The company has received a Venture Round investment at 01 January 2011 from HYGEA VCT PLC. MI's expertise lies in creating high-quality gene expression and proteomics arrays, with a focus on advancing array-based technologies for various applications, including analyte testing, diagnostics, pathogen identification, and personalized medicine. MI's origins can be traced back to the Microarray Core facility of the Vanderbilt-Ingram Comprehensive Cancer Center in Nashville, Tennessee. It evolved from the proficiency and printing innovations developed at the Cancer Center, leading to its establishment as an independent company in November 2000. Presently, MI operates as a resident associate company in the HudsonAlpha Institute for Biotechnology in Huntsville, AL, and has been privately held since May 2010. The company's array-based technologies aim to mimic complex molecular associations found in vivo, requiring consideration of various physical and biological factors. MI's specialization in immobilizing DNA, proteins, and other small molecules onto a range of array surface types provides clients with exceptional opportunities to achieve unique and high-quality results for their research and diagnostic needs in the biotechnology and analytics industries.